Doxorubicin and ifosfamide-mesna in advanced and recurrent uterine sarcomas

European Journal of Gynaecological Oncology

Volumn 26, Issue 3, 2005, Pages 275-278

  Piura, B ^a   Rabinovich, A ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Chemotherapy; Disease response; Doxorubicin; Ifosfamide; Toxicity; Uterine sarcoma

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; MITOXANTRONE;

ABDOMINAL HYSTERECTOMY; ADULT; ADVANCED CANCER; ALOPECIA; ANEMIA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; ISRAEL; LEUKOPENIA; NEUTROPENIA; RECURRENT CANCER; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY; THROMBOCYTOPENIA; UTERUS SARCOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; FEMALE; HUMANS; IFOSFAMIDE; MESNA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROTECTIVE AGENTS; RETROSPECTIVE STUDIES; SARCOMA; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 21044433584     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Mansi J.L., Fisher C., Wiltshaw E., MacMillan S., King M., Stuart-Harris R.: "A phase I-II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma". Eur. J. Cancer Clin. Oncol., 1988, 24, 1439.
2. Schutte J., Kellner R., Seeber S.: "Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen". Cancer Chemother. Pharmacol., 1993, 31, S194.
3. Schutte J., Mouridsen H.T., Stewart W., Santoro A., van Oosterom A.T., Somers R. et al.: "Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma". Eur. J. Cancer, 1990, 26, 558.
4. Loehrer P.J. Sr., Sledge G.W. Jr., Nicaise C., Usakewicz J., Hainsworth J.D., Martelo O.J. et al.: "Ifosfamide plus doxorubicin in metastatic adult sarcomas. A multi-institutional phase II trial". J. Clin. Oncol., 1989, 7, 1655.
5. Weh H.J., Zugel M., Wingberg D., Schwarz R., Zornig C., Dietel M., Hossfeld D.K.: "Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or Adriamycin and ifosfamide". Onkologie, 1990, 13, 448.
6. Steward W.P., Verweij J., Somers R., Spooner D., Kerbrat P., Clavel M. et al: "Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer, Soft Tissue and Bone Sarcoma Group". J. Clin. Oncol., 1993, 11, 15.
7. Edmonson J.H., Ryan L.M., Blum R.H., Brooks J.S., Shiraki M., Frytak S., Parkinson D.R.: "Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas". J. Clin. Oncol., 1993, 11, 1269.
8. Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y. et al.: "Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy". J. Surg. Oncol., 2000, 73, 12.
9. Myers C.E., Chabner B.A.: "Anthracyclines". In: Chabner B.A., Collins J.M. (eds.), Cancer Chemotherapy: Principles and Practice, Philadelphia, J.B. Lippincott Company, 1990, 356.
10. Colvin M., Chabner B.A.: "Alkylating agents". In: Chabner BA., Collins J.M. (eds.), Cancer Chemotherapy: Principles and Practice, Philadelphia, J.B. Lippincott Company, 1990, 276.
11. Piura B., Rabinovich A., Yanai-Inbar I., Cohen Y., Glezerman M.: "Uterine sarcoma in the south of Israel: study of 36 cases". J. Surg. Oncol., 1997, 64, 55.
12. Levin L., Hryniuk W.M.: "Dose intensity analysis of chemotherapy regimens in ovarian carcinoma". J. Clin. Oncol., 1987, 5, 756.
13. Levin L., Hryniuk W.M.: "The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer". Semin. Oncol., 1987, 14 (suppl. 4), 12.
14. Common Terminology Criteria for Adverse Events, Version 3.0, Revised June 10, 2003, National Cancer Institute, http://ctep.cancer.gov/forms/CTCAEv3.pdf
15. Omura G.A., Major F.J., Blessing J.A., Sedlacek T.V., Thigpen J.T., Creasman W.T., Zaino R.T.: "A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas". Cancer, 1983, 52, 626.
16. Sutton G.P., Blessing J.A., Rosenshein N., Photopulos G., DiSaia P.J.: "Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group study)". Am. J. Obstet. Gynecol., 1989, 161, 309.
17. Hawkins R.E., Wiltshaw E., Mansi J.L.: "Ifosfamide with or without adriamycin in advanced uterine leiomyosarcoma". Cancer Chemother. Pharmacol., 1990, 26, S26.
18. Sutton G.P., Blessing J.A., Barrett R.J., McGehee R.: "Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecololgic Oncology Group study". Am. J. Obstet. Gynecol., 1992, 166, 556.
19. Sutton G., Blessing J.A., Park R., DiSaia P.J., Rosenshein N.: "Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group". Obstet. Gynecol., 1996, 87, 747.
20. Sutton G., Blessing J.A., Malfetano J.H.: "Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: A Gynecologic Oncology Group Study". Gynecol. Oncol., 1996, 62, 226.
21. Sutton G., Brunette V.L., Kilgore L., Soper J.T., McGehee R., Olt G., et al.: "A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group study". Gynecol. Oncol., 2000, 79, 147.